跳至主要内容
临床试验/NL-OMON39763
NL-OMON39763已完成不适用

CIP Pulsecath iVAC2L in High-Risk PCI patients - Pulsecath iVAC2

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Indicated for High-Risk PCI, according to hospital standard procedure
  • * Indicated to have an IABP during the PCI, according to hospital standard procedure
  • * Expected duration of iVAC2L support: maximum 24 hours
  • * Patient older than 18 years
  • * Patient has signed the Informed Consent

排除标准

  • * Aortic disease: ascending aortic aneurism, severe calcified aorta
  • * Aortic valvular disease: severe aortic valve stenosis, severe aortic valve insufficiency
  • * Aortic mechanical valve prosthesis
  • * Thrombus in left ventricle
  • * Intra ventricular septum defect
  • * Severe peripheral vascular disease
  • * No functioning right ventricle
  • * History of coagulation disorders
  • * Participation in another clinical study that may interfere with this study

研究者

相似试验